The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans
Open accessAbstract
The essential contribution of the antidepressant-sensitive serotonin (5-HT) transporter SERT (which is encoded by the SLC6A4 gene) to platelet 5-HT stores suggests an important role of this transporter in platelet function. Here, using SERT-deficient mice, we have established a role for constitutive SERT expression in efficient ADP- and thrombin-triggered platelet aggregation. Additionally, using pharmacological blockers of SERT and the vesicular monoamine transporter (VMAT), we have identified a role for ongoing 5-HT release and SERT activity in efficient human platelet aggregation. We have also demonstrated that fibrinogen, an activator of integrin alphaIIbbeta3, enhances SERT activity in human platelets and that integrin alphaIIbbeta3 interacts directly with the C terminus of SERT. Consistent with these findings, knockout mice lacking integrin beta3 displayed diminished platelet SERT activity. Conversely, HEK293 cells engineered to express human SERT and an activated form of integrin beta3 exhibited enhanced SERT function that coincided with elevated SERT surface expression. Our results support an unsuspected role of alphaIIbbeta3/SERT associations as well as alphaIIbbeta3 activation in control of SERT activity in vivo that may have broad implications for hyperserotonemia, cardiovascular disorders, and autism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“linkage studies in ASD have implicated the 17q11.2 region containing Slc6a4 [50, 51].”
From Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders (2018) · cites this paper as [51]
Citations
Cites
Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D. E., Heils, A., Mößner, R., Westphal, H., & Lesch, K. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.649 · Cited by 719
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 614
Gershon, M. D. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02180.x · Cited by 521
Integrin signaling to the actin cytoskeleton
DeMali, K. A., Wennerberg, K., & Burridge, K. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00109-1 · Cited by 511
Walther, D. J., Peter, J.-U., Winter, S., Höltje, M., Paulmann, N., Grohmann, M., Vowinckel, J., Alamo-Bethencourt, V., Wilhelm, C. S., Ahnert-Hilger, G., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)01014-6 · Cited by 475
Ramamoorthy, S., & Blakely, R. (1999) · Science · doi:10.1126/science.285.5428.763 · Cited by 392
Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse
Chavis, P., & Westbrook, G. L. (2001) · Nature · doi:10.1038/35077101 · Cited by 332
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
Eddahibi, S., Hanoun, N., Lanfumey, L., Lesch, K., Raffestin, B., Hamon, M., & Adnot, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8678 · Cited by 330
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype
Ozaki, N., Goldman, D. A., Kaye, W. H., Plotnicov, K. H., Greenberg, B. D., Lappalainen, J., Rudnick, G., & Murphy, D. L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001365 · Cited by 275
Qian, Y., Melikian, H. E., Rye, D., Levey, A. I., & Blakely, R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01261.1995 · Cited by 256
Cited by
Sorted by citations
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 874
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112345109 · Cited by 333
Self-citationSerotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions
Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019) · International Journal of Tryptophan Research · doi:10.1177/1178646919873925 · Cited by 288
Molecular Mechanisms of SERT in Platelets: Regulation of Plasma Serotonin Levels
Mercado, C. P., & Kilic, F. (2010) · Molecular Interventions · doi:10.1124/mi.10.4.6 · Cited by 262
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
Sukhatme, V. P., Reiersen, A. M., Vayttaden, S. J., & Sukhatme, V. V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652688 · Cited by 193
Wang, F., Knutson, K. R., Alcaino, C., Linden, D. R., Gibbons, S. J., Kashyap, P., Grover, M., Oeckler, R. A., Gottlieb, P. A., Li, H. J., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272718 · Cited by 188
Vesicular and Plasma Membrane Transporters for Neurotransmitters
Blakely, R. D., & Edwards, R. H. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005595 · Cited by 169
Self-citationDeveloping zebrafish models of autism spectrum disorder (ASD)
Stewart, A., Nguyen, M., Wong, K., Poudel, M. K., & Kalueff, A. V. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.014 · Cited by 160
Regulation of monoamine transporters: Role of transporter phosphorylation
Ramamoorthy, S., Shippenberg, T. S., & Jayanthi, L. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.009 · Cited by 151
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
Going with the Flow: Trafficking‐Dependent and ‐Independent Regulation of Serotonin Transport
Steiner, J. A., Carneiro, A. M. D., & Blakely, R. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00757.x · Cited by 127
Enhanced activity of human serotonin transporter variants associated with autism
Prasad, H. C., Steiner, J. A., Sutcliffe, J. S., & Blakely, R. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0143 · Cited by 126
Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders
Israelyan, N., & Margolis, K. G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.020 · Cited by 122
Ontogeny and regulation of the serotonin transporter: Providing insights into human disorders
Daws, L. C., & Gould, G. G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.013 · Cited by 121
Carter, M. D., Shah, C. R., Muller, C. L., Crawley, J. N., Carneiro, A. M. D., & Veenstra-VanderWeele, J. M. (2011) · Autism Research · doi:10.1002/aur.180 · Cited by 113
Platelets: emerging facilitators of cellular crosstalk in rheumatoid arthritis
Olumuyiwa-Akeredolu, O.-O. O., Pagé, M., Soma, P., & Pretorius, E. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0187-9 · Cited by 105
Bismuth-Evenzal, Y., Gonopolski, Y., Gurwitz, D., Iancu, I., Weizman, A., & Rehavi, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.013 · Cited by 101
Neural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders
Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 97
Liang, C., Lee, Y. H., Thein, T.-L., Fang, J., Pang, J., Ooi, E. E., Leo, Y., Ong, C. N., & Tannenbaum, S. R. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004607 · Cited by 93
Reprint of: Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders
Israelyan, N., & Margolis, K. G. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.023 · Cited by 87
Bipolar disorder in adults with Asperger׳s Syndrome: A systematic review
Vannucchi, G., Masi, G., Toni, C., Dell’Osso, L., Erfurth, A., & Perugi, G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.042 · Cited by 96
Garbarino, V. R., Gilman, T. L., Daws, L. C., & Gould, G. G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.010 · Cited by 85
Platelet δ-Storage Pool Disease: An Update
Dupuis, A., Bordet, J., Eckly, A. E., & Gachet, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082508 · Cited by 84
Chang, J. C., Tomlinson, I. D., Warnement, M. R., Ustione, A., Carneiro, A. M. D., Piston, D. W., Blakely, R., & Rosenthal, S. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0048-12.2012 · Cited by 78
Human platelets and their capacity of binding viruses: meaning and challenges?
Chabert, A., Hamzeh‐Cognasse, H., Pozzetto, B., Cognasse, F., Schattner, M. A., Gomez, R. M., & Garraud, O. (2015) · BMC Immunology · doi:10.1186/s12865-015-0092-1 · Cited by 78
Platelet function alterations in dengue are associated with plasma leakage
Alisjahbana, B., de Groot, P. G., Indrati, A. R., Fijnheer, R., Puspita, M., Dewi, I. M. W., van de Wijer, L., de Boer, E. M. S., Roest, M., van der Ven, A. J. A. M., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-01-0056 · Cited by 74
Ziu, E., Mercado, C. P., Li, Y., Singh, P., Ahmed, B. A., Freyaldenhoven, S. T., Lensing, S., Ware, J. L., & Kilic, F. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.004 · Cited by 73
Serotonergic mechanisms enhance platelet-mediated thrombogenicity
López-Vílchez, I., Díaz‐Ricart, M., Navalón, F., Gómez‐Gil, E., Gastó, C., Escolar, G., & Galan, A. M. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0810 · Cited by 75
Liu, Y., Wei, L., Laskin, D. L., & Fanburg, B. L. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0078oc · Cited by 73
iTRAQ‐Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with Autism
Shen, L., Zhang, K., Feng, C., Chen, Y., Li, S., Iqbal, J., Liao, L., Zhao, Y., & Zhai, J. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700085 · Cited by 70
The Role of Serotonin beyond the Central Nervous System during Embryogenesis
Lv, J., & Liu, F. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00074 · Cited by 70
Serotonin as a Mitogen in the Gastrointestinal Tract: Revisiting a Familiar Molecule in a New Role
Shah, P. A., Park, C. J., Shaughnessy, M. P., & Cowles, R. A. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.05.008 · Cited by 70
Oved, K., Morag, A., Pasmanik-Chor, M., Rehavi, M., Shomron, N., & Gurwitz, D. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.86 · Cited by 66
Autocrine and paracrine regulatory functions of platelet serotonin
Mammadova‐Bach, E., Mauler, M., Braun, A., & Duerschmied, D. (2018) · Platelets · doi:10.1080/09537104.2018.1478072 · Cited by 68
Tseng, Y., Chiang, M.-L., Huang, T., Su, K., Lane, H., & Lai, Y.-C. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.09.017 · Cited by 66
The Role of Serotonin beyond the Central Nervous System during Embryogenesis
Lv, J., & Liu, F. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fnpit.2017.00400 · Cited by 65
Lorsung, E., Ramanujam, K., & Cao, R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.642745 · Cited by 67
Novel aspects of enteric serotonergic signaling in health and brain-gut disease
Colle, A. D., Israelyan, N., & Margolis, K. G. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00173.2019 · Cited by 69
Mostafa, G. A., & AL-Ayadhi, L. Y. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-71 · Cited by 60
Integrin adhesion in brain assembly: From molecular structure to neuropsychiatric disorders
Jaudon, F., Thalhammer, A., & Cingolani, L. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14859 · Cited by 59
Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes
Napolioni, V., Lombardi, F., Sacco, R., Curatolo, P., Manzi, B., Alessandrelli, R., Militerni, R., Bravaccio, C., Lenti, C., Saccani, M., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.180 · Cited by 58
Moya, P. R., Wendland, J. R., Rubenstein, L. M., Timpano, K. R., Heiman, G. A., Tischfield, J. A., King, R. A., Andrews, A. M., Ramamoorthy, S., McMahon, F. J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25460 · Cited by 58
Rose’Meyer, R. B. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-37 · Cited by 58
Hyperserotonemia in autism: activity of 5HT-associated platelet proteins
Hranilović, D., Bujas-Petković, Z., Tomičić, M., Bordukalo-Nikšić, T., Blažević, S. A., & Čičin‐Šain, L. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0192-2 · Cited by 54
Multifaceted Regulations of the Serotonin Transporter: Impact on Antidepressant Response
Baudry, A., Pietri, M., Launay, J., Kellermann, O., & Schneider, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00091 · Cited by 59
Steiner, J. A., Carneiro, A. M., Wright, J., Matthies, H. J. G., Prasad, H. C., Nicki, C. K., Dostmann, W. R., Buchanan, C. C., Corbin, J. D., Francis, S. H., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-26 · Cited by 48
Duerschmied, D., Canault, M., Lievens, D., Brill, A. G., Cifuni, S. M., Bäder, M., & Wagner, D. D. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03476.x · Cited by 50
Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders
Mitra, I., Lavillaureix, A., Yeh, E., Traglia, M., Tsang, K. M., Bearden, C. E., Rauen, K. A., & Weiss, L. A. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006516 · Cited by 48
Blood platelet research in autism spectrum disorders: In search of biomarkers
Padmakumar, M., Raes, E. V., Geet, C. V., & Freson, K. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12239 · Cited by 49
Matondo, A. B., Punt, C. A., Homberg, J. R., Toussaint, M. J. M., Kisjes, R., Korporaal, S. J. A., Akkerman, J. W. N., Cuppen, E. P. J. G., & de Bruin, A. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90709.2008 · Cited by 46
Dystrophic Serotonin Axons in Postmortem Brains from Young Autism Patients
Azmitia, E. C., Singh, J. S., Hou, X. P., & Węgiel, J. (2011) · The Anatomical Record · doi:10.1002/ar.21243 · Cited by 46
Hallbäck, I., Hägg, S., Eriksson, A. C., & Whiss, P. A. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70894-0 · Cited by 45
Cell Adhesion Molecules and Their Involvement in Autism Spectrum Disorder
Ye, H., Liu, J., & Wu, J. Y. (2010) · Neurosignals · doi:10.1159/000322543 · Cited by 45
Veenstra-VanderWeele, J. M., Jessen, T. N., Thompson, B. J., Carter, M. D., Prasad, H. C., Steiner, J. A., Sutcliffe, J. S., & Blakely, R. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9020-0 · Cited by 43
Abdel-Malik, N., Ruhé, H. G., Barwari, K., van den Dool, E. J., Meijers, J. C. M., Middeldorp, S., Buller, H. R., Schene, A. H., & Kamphuisen, P. W. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03196.x · Cited by 40
Serotonin transporter and integrin beta 3 genes interact to modulate serotonin uptake in mouse brain
Whyte, A. J., Jessen, T. N., Varney, S., & Carneiro, A. M. D. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.014 · Cited by 40
Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis
Rami, M., Guillamat‐Prats, R., Rinne, P., Salvermoser, M., Ring, L., Bianchini, M., Blanchet, X., Megens, R. T. A., Döring, Y., Walzog, B., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310536 · Cited by 39
Origin of the blood hyperserotonemia of autism
Janušonis, S. (2008) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-5-10 · Cited by 38
Tseng, Y., Chiang, M.-L., Lane, H., Su, K., & Lai, Y.-C. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.02.007 · Cited by 37
SSRI use and clinical outcomes in epithelial ovarian cancer
Christensen, D., Armaiz-Peña, G., Ramírez, E., Matsuo, K., Zimmerman, B., Zand, B., Shinn, E., Goodheart, M., Bender, D., Thaker, P., et al. (2016) · OncoTarget · doi:10.18632/oncotarget.8891 · Cited by 32
Baganz, N. L., Lindler, K. M., Zhu, C.-B., Smith, J., Robson, M. J., Iwamoto, H., Deneris, E. S., Hewlett, W. A., & Blakely, R. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.168 · Cited by 36
Monassier, L., Laplante, M., Ayadi, T., Doly, S., & Maroteaux, L. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.004 · Cited by 37
Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice
Kerr, T. M., Muller, C. L., Miah, M. R., Jetter, C. S., Pfeiffer, R., Shah, C. R., Baganz, N. L., Anderson, G. M., Crawley, J. N., Sutcliffe, J. S., et al. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-35 · Cited by 39
Neuronal cell adhesion genes and antidepressant response in three independent samples
Fabbri, C., Crisafulli, C., Gurwitz, D., Stingl, J., Calati, R., Albani, D., Forloni, G., Calabrò, M., Martines, R., Kasper, S. F., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.15 · Cited by 37
Becker, R. C., Dentali, F., Kuhn, C. M., Helms, M. J., Ortel, T. L., Williams, R. B., & Berger, J. S. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0202 · Cited by 36
Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders
Mitroshina, E., Marasanova, E., & Vedunova, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216416 · Cited by 34
The role of serotonin in haemostasis
Bode, C., & Duerschmied, D. (2009) · Hämostaseologie · doi:10.1055/s-0037-1617140 · Cited by 36
HTR1B and HTR2C in autism spectrum disorders in Brazilian families
Orabona, G. M., Griesi‐Oliveira, K., Vadasz, E., Bulcão, V. L. S., Takahashi, V. N. V. O., Moreira, E. S., Furia-Silva, M., Ros-Melo, A. M. S., Dourado, F., Matioli, S. R., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.007 · Cited by 35
Brief Report: Platelet-Poor Plasma Serotonin in Autism
Anderson, G. M., Hertzig, M. E., & McBride, P. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1371-1 · Cited by 35
The role of Rab38 in platelet dense granule defects
Ninkovic, I., White, J. G., Rangel-Filho, A., & Datta, Y. H. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03178.x · Cited by 32
Mazalouskas, M. D., Jessen, T. N., Varney, S., Sutcliffe, J. S., Veenstra-VanderWeele, J. M., Cook, E. H., & Carneiro, A. M. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.51 · Cited by 31
Singh, A. S., Chandra, R., Guhathakurta, S., Sinha, S., Chatterjee, A., Ahmed, S., Ghosh, S., & Rajamma, U. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.015 · Cited by 34
Acquired platelet function disorders
Brennan, Y., Levade, M., & Wård, C. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.06.009 · Cited by 32
The role of β3 integrin gene variants in Autism Spectrum Disorders — Diagnosis and symptomatology
Schuch, J. B., Müller, D., Endres, R. G., Bosa, C. A., Longo, D., Schüler‐Faccini, L., Ranzan, J., Becker, M. M., Riesgo, R. D. S., & Roman, T. (2014) · Gene · doi:10.1016/j.gene.2014.09.058 · Cited by 32
The role of integrins in brain health and neurodegenerative diseases
Cui, Y., Rõlova, T., & Fagerholm, S. C. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151441 · Cited by 32
Zhu, C.-B., Lindler, K. M., Campbell, N. G., Sutcliffe, J. S., Hewlett, W. A., & Blakely, R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071399 · Cited by 30
Ren, W., Watts, S. W., & Fanburg, B. L. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00237.2010 · Cited by 30
Hoirisch-Clapauch, S., Nardi, A. E., Gris, J., & Brenner, B. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.028 · Cited by 31
The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain
Dohn, M. R., Kooker, C. G., Bastarache, L. A., Jessen, T. N., Rinaldi, C., Varney, S., Mazalouskas, M. D., Pan, H., Oliver, K. H., Edwards, D. R. V., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1482-17.2017 · Cited by 28
Nurden, A. T. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.03.005 · Cited by 29
Oliver, K. H., Duvernay, M. T., Hamm, H. E., & Carneiro, A. M. D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.736983 · Cited by 28
Wolf, K., Braun, A., Haining, E. J., Tseng, Y., Kraft, P., Schuhmann, M. K., Gotru, S. K., Chen, W., Hermanns, H. M., Stoll, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147664 · Cited by 28
Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport
Roweth, H. G., Yan, R., Bedwani, N. H., Chauhan, A., Fowler, N., Watson, A. H., Malcor, J.-D. M., Sage, S. O., & Jarvis, G. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21348-3 · Cited by 26
Quinlan, M. A., Robson, M. J., Ye, R., Rose, K. L., Schey, K. L., & Blakely, R. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00089 · Cited by 27
Pagan, C., Benabou, M., Leblond, C. S., Cliquet, F., Mathieu, A., Lemière, N., Goubran‐Botros, H., Delorme, R., Leboyer, M., Callebert, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01125-5 · Cited by 28
Campbell, N. G., Zhu, C.-B., Lindler, K. M., Yaspan, B. L., Kistner‐Griffin, E., Hewlett, W. A., Tate, C. G., Blakely, R., & Sutcliffe, J. S. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-28 · Cited by 28
Kyzar, E. J., Pham, M., Roth, A., Cachat, J., Green, J. B. A., Gaikwad, S., & Kalueff, A. V. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.08.004 · Cited by 25
Seimandi, M., Seyer, P., Park, C. S., Vandermoere, F., Chanrion, B., Bockaert, J., Mansuy, I. M., & Marin, P. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0076-13.2013 · Cited by 25
Martins‐de‐Souza, D., Maccarrone, G., Ising, M., Kloiber, S. M., Lucae, S., Holsboer, F., & Turck, C. W. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.022 · Cited by 25
Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?
Shuffrey, L. C., Guter, S. J., Delaney, S., Jacob, S., Anderson, G. M., Sutcliffe, J. S., Cook, E. H., & Veenstra-VanderWeele, J. M. (2017) · Autism Research · doi:10.1002/aur.1791 · Cited by 25
Platelet Serotonin Transporter Function Predicts Default-Mode Network Activity
Scharinger, C., Rabl, U., Kasess, C. H., Meyer, B. M., Hofmaier, T., Diers, K., Bartova, L., Pail, G., Huf, W., Uzelac, Ž., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092543 · Cited by 27
Yu, W., Yen, Y.-C., Lee, Y., Tan, S., Xiao, Y., Lokman, H., Ting, A. K. T., Ganegala, H. E. W., Kwon, T., Ho, W., et al. (2019) · Molecular Brain · doi:10.1186/s13041-019-0452-5 · Cited by 27
Differential regulation of serotonin transporter cell surface expression
Lau, T., & Schloss, P. D. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.10 · Cited by 23
The C-Terminal Region of Serotonin Transporter Is Important for Its Trafficking and Glycosylation
Nobukuni, M., Mochizuki, H., Okada, S., Kameyama, N., Tanaka, A., Yamamoto, H., Amano, T., Seki, T., & Sakai, N. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09195fp · Cited by 23
Afarideh, M., Behdadnia, A., Noshad, S., Mirmiranpour, H., Mousavizadeh, M., Khajeh, E., Rad, M. V., Mazaheri, T., Nakhjavani, M., & Esteghamati, A. (2015) · Endocrine Practice · doi:10.4158/ep14442.or · Cited by 23
Probst-Schendzielorz, K., Scholl, C., Efimkina, O., Ersfeld, E., Viviani, R., Serretti, A., Fabbri, C., Gurwitz, D., Lucae, S., Ising, M., et al. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.31 · Cited by 23
MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action
Oved, K., Farberov, L., Gilam, A., Israel‐Elgali, I., Haguel, D., Gurwitz, D., & Shomron, N. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00355 · Cited by 22
Two novel, putative mechanisms of action for citalopram-induced platelet inhibition
Roweth, H. G., Cook, A. A., Moroi, M., Bonna, A., Jung, S. M., Bergmeier, W., Sage, S. O., & Jarvis, G. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-34389-5 · Cited by 21
Metadata
- Authors
- Carneiro, A. M. D., Cook, E. H., Murphy, D. L., & Blakely, R. D.
- Affiliations
- Vanderbilt University (US)
- University of Illinois Chicago (US)
- National Institutes of Health (US)
- Corresponding author
- Blakely, Randy D.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-04-01
- Volume
- 118
- Issue
- 4
- Pages
- 1544-1552
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2260909
- OpenAlex
- W2144374554
- Cited by
- 180
- References
- 50
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 3 · 2019: 13 · 2018: 10 · 2017: 14 · 2016: 9 · 2015: 9 · 2014: 14 · 2013: 13 · 2012: 14
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health (P50MH078028, MH078028, NIMH P50)
- National Institute on Drug Abuse (R01DA007390, DA007390)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U19-HD 35482, U19HD035482)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- serotonin transporter, integrin αIIbβ3, platelet aggregation, serotonin release, vesicular monoamine transporter, fibrinogen, ADP-induced aggregation, thrombin-induced aggregation, hyperserotonemia, autism spectrum disorder, cardiovascular disease
- MeSH terms
- Alleles, Animals, Biological Transport, Blood Platelets, Cell Line, Cell Membrane, Humans, Platelet Aggregation, Protein Binding, Serotonin, Mice, Knockout, Platelet Glycoprotein GPIIb-IIIa Complex, MAP Kinase Signaling System, p38 Mitogen-Activated Protein Kinases, Serotonin Plasma Membrane Transport Proteins, Mice, Protein Phosphatase 1, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review